Cardiac Arrest Extra Corporeal Oxygenation Membrane
CAREECMO
Refractory Cardiac Arrest Management With Veno-Arterial Extra Corporeal Oxygenation Membrane Registry
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
French guidelines for Cardio Pulmonary Resuscitation (CPR) consider Extra-Corporeal Life Support (ECLS) as one option in Refractory out-of hospital Cardiac Arrest (ROHCA) patients with a no-flow less than five minutes and absence of spontaneous circulation 30 minutes after initiation of advanced CPR. Duration of both pre-CPR arrest (no-flow) and of CPR (low-flow) have been systematically highlighted as crucial prognostic factors in all observational studies focused on ROHCA. In order to shorten the time to ECLS initiation, the most recent European Resuscitation Council guidelines recommend, in eligible ROHCA patients, a fast track access to ECLS implantation. CHRU Nancy elaborated an operational strategy which was designed to improve the enrolment of eligible ROHCA patients and to reduce the delay time between recognition and ECLS initiation. The objective of the present register was to assess prospectively the impact of this new operational strategy over a 5 years period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2017
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2017
CompletedFirst Posted
Study publicly available on registry
November 24, 2017
CompletedStudy Start
First participant enrolled
December 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedNovember 24, 2017
November 1, 2017
5 years
November 16, 2017
November 22, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of survivors without neurological sequelae Number of survivors without neurological sequelae (DRS scale from 0 to 6)
Number of survivors without neurological sequelae (DRS scale from 0 to 6)
1 year
Secondary Outcomes (16)
Number of survivors with or without neurological sequelae.
at 3 months
Number of survivors with or without neurological sequelae.
at 3 months
Ischemia-reperfusion assessment
from ECMO implantation and day 3
Renal failure
ECMO implantation - Day 1- Day 3
Hepatic failure
ECMO implantation - Day 1 - Day 3
- +11 more secondary outcomes
Study Arms (1)
ROHCA rescued by vaECMO
OTHERPatients experiencing a ROHCA despite advanced CPR and finally rescued with a va ECMO device.
Interventions
ROHCA must be witnessed with onset of bystander CPR and an immediate call to Emergency Dispatch. Furthermore, to minimize any loss of time, all qualified geographical locations are directly incorporated in the regulation software of the center for medical emergency control. Patients suitable for vaECMO implantation were identified as early as possible by the Medical Dispatcher at the Emergency Call Dispatch Center. Bystanders pursued CPR until Mobile Intensive Care Unit (MICU) arrival. OHCA was considered refractory after 10 min of CPR initiating the transport by MICU to the hospital such that the vaECMO intervention could be performed. The resuscitation was pursued during the transfer to hospital. An automated chest compression device was used in order to minimize interruption periods. The intensivists and cardiac surgeons stood ready to implant the vaECMO surgically in the catheterization laboratory where a percutaneous coronary intervention was subsequently performed.
Eligibility Criteria
You may qualify if:
- Witnessed out-of-hospital cardiac arrest
- in qualified geographical locations
- No Return of spontaneous circulation (ROSC) after 10 min of CPR
- No Flow \<1 min
You may not qualify if:
- Apparent obvious comorbidities
- Patient \< 18 yo
- Pregnancy
- Patient under protective supervision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Chouihed T, Kimmoun A, Lauvray A, Laithier FX, Jaeger D, Lemoine S, Maureira JP, Nace L, Duarte K, Albizzati S, Girerd N, Levy B. Improving Patient Selection for Refractory Out of Hospital Cardiac Arrest Treated with Extracorporeal Life Support. Shock. 2018 Jan;49(1):24-28. doi: 10.1097/SHK.0000000000000941.
PMID: 28682938RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antoine Kimmoun, MD
CHRU Nancy
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2017
First Posted
November 24, 2017
Study Start
December 1, 2017
Primary Completion
December 1, 2022
Study Completion
December 1, 2023
Last Updated
November 24, 2017
Record last verified: 2017-11